Remove 2022 Remove Healthcare Remove Leads
article thumbnail

A realistic view of healthcare in 2022

World of DTC Marketing

Yes, there will be changes in healthcare in the coming years but put away the thoughts that telehealth and wearable devices will revolutionize healthcare. Digital, within healthcare, is used differently by online health seekers. The post A realistic view of healthcare in 2022.

article thumbnail

Looking back at 2022: The top healthcare stories

Pharmaceutical Technology

The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. Tracking the diversity push. Tracking the latest trends.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

The four devices will be put through their paces in real-world healthcare settings via pilot projects in Norway, Belgium, Slovenia, Spain, and Germany. — Circular Digital Health (DiCE project) (@circular_health) October 13, 2022. The post Janssen leads effort to cut waste in digital health devices appeared first on.

Leads 124
article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Regulation, particularly Annex 1, was identified as a key focus for 2022.

article thumbnail

Anthropy 2022 – Day One

pharmaphorum

Wednesday 2 nd November heralds the start of Anthropy 2022 at The Eden Project. The post Anthropy 2022 – Day One appeared first on.

Pharma 98
article thumbnail

CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials

Fierce Pharma

Following Nucleus RadioPharma’s 2022 debut, the GE HealthCare- and Mayo Clinic-backed radiopharmaceuticals CDMO is ready to put its production thesis to the test. The production deal will support ARTBIO’s planned phase 1 and 2 clinical trials of its lead program in prostate cancer, AB001.

article thumbnail

Pfizer’s Covid-19 vaccine sales forecasts upgraded with sales of $37bn in 2022

Pharmaceutical Technology

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast.

Sales 98